home / stock / adtx / adtx news


ADTX News and Press, ADiTx Therapeutics Inc. From 08/18/23

Stock Information

Company Name: ADiTx Therapeutics Inc.
Stock Symbol: ADTX
Market: NASDAQ
Website: aditxt.com

Menu

ADTX ADTX Quote ADTX Short ADTX News ADTX Articles ADTX Message Board
Get ADTX Alerts

News, Short Squeeze, Breakout and More Instantly...

ADTX - Why Is Aditxt (ADTX) Stock Up 10% Today?

2023-08-18 13:14:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of biotechnology firm Aditxt (NASDAQ: ADTX ) — which specializes in therapeutics and technologies that monitor and modulate the immune system — popped up 25% on...

ADTX - Aditxt Inc. (NASDAQ: ADTX) Leading the Way in Friday Trading Based on Percentage Gain

Aditxt, Inc. (NASDAQ: ADTX) is one of today's top gainers. The company's shares are currently up 4,621% on the day to $18.86. Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring. It develops Adi...

ADTX - Aditxt, AlloVir top healthcare gainers; Evelo, Diffusion among losers

2023-08-18 10:19:27 ET Gainers: Aditxt ( ADTX ) +50% . AlloVir ( ALVR ) +18% . Agenus ( AGEN ) +7% . Veru ( VERU ) +7% . Akari Therapeutics ( AKTX ) +6% . Losers: Evelo Biosciences ( EVLO ) -37% . Diffusi...

ADTX - Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial Scale

Aditxt®, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on innovation and activation of precision medicine therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update ...

ADTX - Aditxt announces 1-for-40 reverse stock split

2023-08-17 13:38:12 ET More on Aditx Therapeutics Aditxt stock rises ~10% on plans to buy 50% stake in Global Response Aid from Cellvera Aditxt dips on pricing of $20M public offering For further details see: Aditxt announces 1-for-40 reverse stock split

ADTX - Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced today that it will effect a 1-for-40 reverse split of its common stock effective as of 9:30 a.m....

ADTX - InvestorNewsBreaks - Aditxt Inc.'s (NASDAQ: ADTX) Pearsanta Inc. Enters LOI to Acquire Natural State Laboratories and Natural State Genomics

Aditxt (NASDAQ: ADTX) , a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, today announced the signing of an exclusive non-binding letter of intent (“LOI”) by its wholly owned subsidiary, Pearsanta(TM) Inc., to acquire b...

ADTX - Aditxt, Inc.'s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and Genetic Testing with a Non-Binding Letter of Intent to Acquire Natural State Laboratories and Natural State Genomics

The proposed acquisition is expected to act as a catalyst for strategic revenues while strengthening Pearsanta’s operational infrastructure and product offerings. The proposed acquisition is also intended to bring additional depth to Pearsanta’s roster of top-tier scientists and exe...

ADTX - Best Penny Stocks To Buy? 4 Under $1.10 To Watch Now

2023-05-05 13:09:12 ET The simple definition of penny stocks includes stocks under $5. Some traders might say they are limited to only the Over-The-Counter or “OTC exchange.” But in reality, plenty of cheap stocks are trading on larger exchanges. In the stock market today,...

ADTX - InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Subsidiary Inks Stiff Person Syndrome Clinical Trial Agreement with Mayo Clinic

Aditxt (NASDAQ: ADTX) , a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, and its subsidiary Adimune(TM) Inc. announced a clinical trial agreement with Mayo Clinic. The clinical trial, which is designed to advance clinical studi...

Previous 10 Next 10